The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Cholestyramine Resin Therapy for Hypercholesteremia: Clinical and Metabolic Studies
Abstract
Cholestyramine resin, a bile-acid-sequestering agent, was administered to nine hypercholesteremic patients for periods of one month to four years. By promoting fecal excretion of bile acids, the resin appears to induce an increase in the rate of cholesterol conversion to bile acids in the liver, often resulting in a diminution of plasma cholesterol levels. During daily treatment with 13.3 gm of cholestyramine, eight of the subjects achieved mean serum total cholesterol levels that ranged from 80% to 50% of the average control values. The decreases were sustained for the duration of treatment. Two patients and one normal subject exhibited marked increases in fecal bile-acid excretion during resin administration, but neutral sterol output did not change consistently. The preparation produced occasional gastrointestinal discomfort; however, systemic side effects were not encountered.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The treatment of pruritus and hypercholesteremia of primary biliary cirrhosis with cholestyramine
Van Itallie, T. B., Hashim, S. A., Crampton, R. S., & Tennent, D. M. (1961) · New England Journal of Medicine · doi:10.1056/nejm196109072651004 · Cited by 110
Self-citation
Cited by
PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE
Miller, G. J., & Miller, N. E. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92376-4 · Cited by 2,621
Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and Disorders
Fredrickson, D. S., Levy, R. I., & Lees, R. S. (1967) · New England Journal of Medicine · doi:10.1056/nejm196701052760107 · Cited by 1,910
Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and Disorders
Fredrickson, D. S., Levy, R. I., & Lees, R. S. (1967) · New England Journal of Medicine · doi:10.1056/nejm196701262760406 · Cited by 361
Cholestyramine Promotes Receptor-Mediated Low-Density-Lipoprotein Catabolism
Shepherd, J., Packard, C. J., Bicker, S., Lawrie, T. D. V., & Morgan, H. G. (1980) · New England Journal of Medicine · doi:10.1056/nejm198005293022202 · Cited by 357
Binding of Bile Salts in vitro by Nonnutritive Fiber
Kritchevsky, D., & Story, J. A. (1974) · The Journal of Nutrition · doi:10.1093/jn/104.4.458 · Cited by 309
Metadata
- Authors
- Hashim, S. A.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 1965-04-26
- Volume
- 192
- Issue
- 4
- Pages
- 289
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2153303712
- Cited by
- 171
- References
- 1
- FWCI
- 24.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cholestyramine Resin Therapy for Hypercholesteremia: Clinical and Metabolic Studies. https://app.cochat.ai/papers/10.1001/jama.1965.03080170017004
- The paper
- Hashim, S. A. (1965). Cholestyramine Resin Therapy for Hypercholesteremia: Clinical and Metabolic Studies. JAMA. https://doi.org/10.1001/jama.1965.03080170017004
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.